Animal Intestinal Health Market Size

The global animal intestinal health market size was valued at $4.17 billion in 2024 and is projected to reach $8.68 billion by 2030, growing at a CAGR of 13.0% during the forecast period.

Animal Intestinal Health Market Overview

Animal intestinal health refers to the overall well-being and proper functioning of the gastrointestinal system in animals, including mammals, birds, and other species. The gastrointestinal system plays a crucial role in an animal's overall health and is responsible for various functions, including digestion, absorption of nutrients, and immune system support. Maintaining good intestinal health in animals is vital for their growth, development, and overall well-being.

Animal Intestinal Health Market Dynamics

• The animal intestinal health market is expected to witness significant growth in the future due to the inclination towards natural growth promoters, a rise in incidences of intestinal disorders among livestock species, and growing awareness about feed and food safety.

• Additionally, the rise in demand for meat and meat products and the increase in the importance of protein-rich diets among consumers across the globe are the prominent factors driving the growth of the animal intestinal health market demand.

• However, the stringent regulations regarding the use of different feed additives and the high cost of raw materials are restraining the market growth.

• On the contrary, innovations and technological advancements in the feed industry are creating opportunities for market growth.

Impact of COVID-19 on the Animal Intestinal Health Market

During the pandemic, there was an increased focus on pet ownership and animal health. Many pet owners sought out high-quality pet food and supplements, which could positively impact the market for products promoting intestinal health. Lockdowns and restrictions affected the ability of pet owners and livestock producers to access veterinary care. Increased awareness of animal welfare issues, especially in the livestock industry, prompted discussions about better feeding practices and the impact on intestinal health. Overall, the impact of COVID-19 on the animal intestinal health market was multifaceted, with both challenges and opportunities arising from shifts in supply chains, consumer behavior, and industry priorities.

By Livestock, the Poultry Segment is projected to be the Largest Segment in the Animal Intestinal Health Market

The poultry segment is projected to be the largest segment in the Animal Intestinal Health market during the forecast period. The demand for products and solutions related to animal intestinal health in the poultry segment has been on the rise due to several factors. Maintaining intestinal health in poultry is crucial for ensuring the overall well-being of the birds and optimizing production. In response to concerns about antibiotic resistance and the need for sustainable poultry production, there has been a push to reduce or eliminate the use of antibiotics as growth promoters. This has led to an increased focus on alternative products to maintain intestinal health. High-quality nutrition and feed formulations are essential for intestinal health in poultry. Specialized feed additives, such as enzymes and amino acids, help poultry digest and absorb nutrients more effectively, improving gut health. This has led to a growing market for specialized products and practices in poultry gut health management.

By Geography, Asia Pacific Region Holds the Dominant Position in the Market Revenue

Asia Pacific holds the dominant position in the market revenue due to the growing population, increasing urbanization, and changing dietary preferences. The Asia Pacific region is home to a significant portion of the world's population. As the population continues to grow, there is a greater need for a sustainable and efficient food supply, including poultry and livestock products. Dietary patterns in the region are shifting toward increased consumption of meat and dairy products. This trend has led to higher demand for poultry and livestock, emphasizing the importance of intestinal health management for efficient production. The Asia Pacific region's dynamic and growing agricultural and food industries, coupled with a focus on sustainability and changing consumer preferences, make it a significant market for products and solutions related to animal intestinal health. Producers are increasingly adopting practices and products to improve gut health, reduce disease risks, and enhance the efficiency of livestock and poultry production.

Key Target Audience:

• Livestock and Poultry Associations

• Environmental and Sustainability Organizations

• Retailers and Distributors

• Regulatory Authorities

• Research and Development Organizations

• Manufacturers and Suppliers

List of the Key Players Profiled in the Report Includes:

• Archer Daniels Midland Company

• Land O'Lakes

• Koninklijke DSM N.V.

• Hansen Holding A/S

• Cargill, Incorporated

• DuPont

• Novozymes

• Nutreco N.V.

• Evonik Industries

• AB Vista

• Unique Biotech

• Lallemand, Inc.

• Pure Cultures

• Alltech

• Calpis Co., Ltd

Recent Developments:

• In April 2023, ADM announced it has licensed AMOBIOME from Gnubiotics, a Swiss biotechnology company renowned for its work in leveraging glycopeptides to bolster the microbiome and promote holistic well-being. AMOBIOME, developed by Gnubiotics, represents an exclusive category of compounds known as glycopeptides, recognized for their ability to enhance digestive health and facilitate the proliferation of beneficial gut bacteria. ADM intends to incorporate these glycopeptide compounds into formulations for dietary supplements and pet food, integrating them into its worldwide supply chain.

• In February 2020, DuPont Nutrition & Biosciences (DuPont) unveiled a collaboration with MRM Health NV (MRM Health). Additionally, MRM Health has confirmed the successful conclusion of its initial external investment round, with the involvement of Ackermans & van Haaren, DuPont, MRM Technologies, Qbic II, and VIB. This collaboration between DuPont and MRM Health is geared toward addressing various metabolic diseases. It will involve the integration of MRM Health's proprietary technology platform with selected DuPont strains to create novel therapeutics based on combinations of live bacterial strains.

Market Segmentation:

The research report includes in-depth coverage of the industry analysis with size, share, and forecast for the below segments:

Market by, Source:

• Plant-based

• Microbial

Market by, Form:

• Liquid

• Dry

Market by, Additive:

• Probiotics

• Immunostimulants

• Prebiotics

• Phytogenics

Market by, Function:

• Metabolism

• Nutrient Digestion

• Weight Gain

• Disease Prevention

• Bone and Joint Health

Market by, Livestock:

• Aquaculture

• Ruminant

• Poultry

• Swine

• Other Livestock's

Market by, Geography:

The animal intestinal health report also analyzes the major geographic regions and countries of the market. The regions and countries covered in the study include:

• North America (The United States, Canada, Mexico), Market Estimates, Forecast & Opportunity Analysis

• Europe (Germany, France, UK, Italy, Spain, Rest of Europe), Market Estimates, Forecast & Opportunity Analysis

• Asia Pacific (China, Japan, India, South Korea, Australia, New Zealand, Rest of Asia Pacific), Market Estimates, Forecast & Opportunity Analysis

• South America (Brazil, Argentina, Chile, Rest of South America), Market Estimates, Forecast & Opportunity Analysis

• Middle East & Africa (UAE, Saudi Arabia, Qatar, Iran, South Africa, Rest of Middle East & Africa), Market Estimates, Forecast & Opportunity Analysis

What can be explored with this research report:

• Understand the key trends that will drive the market and the challenges it faces in the current market scenario.

• Identify growth opportunities.

• Porter's five force analysis.

• In-depth analysis of market segments, and regions/countries predicted to observe promising growth.

• Historical and forecast size of the market in terms of revenue (USD Million).

• Company profiling with key products and solution offerings, key financial information, SWOT analysis, and business strategies adopted.